News

Lighthouse Labs rebrands as Lighthouse Network, shifts focus to long-term founder development

Longtime Richmond accelerator Lighthouse Labs is rebranding to better reflect its commitment to startup founders.

The organization will now be known as Lighthouse Network and will make a “renewed focus” on long-term, human-centered development of founders, it said in its announcement.

“We’ve always believed that when founders thrive, so do their companies,” Debbie Irwin, who became the organization’s executive director in February 2024, said in a statement. “This transition to Lighthouse Network reflects what we’ve been doing for years — walking alongside founders, helping them navigate the messy middle and building the kind of trust and support systems that aren’t found in a typical accelerator.”

The changes include year-round founder support through mentorship, curated investor connections and targeted programming. That will include strategic events like its Founder Network Summit, Investor Connect and Demo Day. Lighthouse will host just one accelerator cohort per year, something it announced in February when it announced the program’s 18th cohort. It previously hosted two a year.

In the past, companies received $20,000 in equity-free financing for being selected to a cohort. But that ended this year, and it instead expanded what it calls “high-impact services” like fractional CFO support, mental health resources and deeper relationship building with investors.

Lighthouse said it will also work to grow a national network rooted in Richmond of founders, mentors and partners committed more to long-term success as opposed to short-term outcomes.

Along with the new name, the rebrand includes a new visual identity, messaging and website that Lighthouse says better reflects its broader vision and nationwide push.

“This isn’t just a name change,” Irwin said in a statement. “It’s a commitment to the people building bold ideas — and a recognition that founders need more than funding to succeed. They need community, connection and a place that sees them as humans first.”

Read more here.

Recent News

10/22/2025

Virginia Catalyst Announces Round 19 of Grant Funding

The Virginia Catalyst announced today that it is accepting letters of intent (LOI) for Grant Round 19 to fund the development and commercialization of life science projects that address major unmet needs for improving human health and advance Virginia’s economy. “We at the Virginia Catalyst are pleased to provide funding in support of the Governor’s

10/21/2025

SRI multi-party team selected as an awardee by ARPA-H to develop at-home screening for ≥30 types of cancers

SRI, along with research partners Foothold Labs and Triple Ring Technologies and commercial partner Beacon Dx Health, has been awarded up to $34 million from the Advanced Research Projects Agency for Health (ARPA-H) to develop technology as part of the POSEIDON (Platform Optimizing SynBio for Early Intervention and Detection in Oncology) program. This pioneering program

10/21/2025

Quoin Pharmaceuticals Announces U.S. FDA Grants Orphan Drug Designation for QRX003 in Netherton Syndrome

Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (“Quoin” or the “Company”), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to its lead product candidate, QRX003, for the treatment of Netherton Syndrome. The designation follows previously granted Orphan